lobbying_activities: 2860598
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2860598 | 61149c45-4c8c-41a2-823d-c30e9b4aeba9 | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | AIM IMMUNOTECH INC. | 2022 | third_quarter | PHA | Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. FY 2023 Appropriations for Defense Department, and National Institutes of Health (NIH). Work with Department of Defense on Ebola countermeasures. | Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Navy, Dept of,SENATE | 20000 | 0 | 0 | 2022-10-05T10:18:09-04:00 |